Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

Gretchen Henkel  |  Issue: September 2013  |  September 1, 2013

Dr. Dougados is also proud of his collaboration during the past two decades with his colleagues in Morocco, especially Najia Hajjaj-Hassouni, MD, chief of the department of rheumatology in Rabat and acting dean of the University of Mohammed V-Souissi there. “I have the arrogance to think that I have contributed to the success of Moroccan rheumatology,” says Dr. Dougados. “The annual scientific meeting is of high quality and the number of peer review manuscripts coming from Morocco is impressive.”

Another example of Dr. Dougados’ vision was his promotion of the 3E [Evidence, Expertise, and Exchange] Initiative in Rheumatology, originally a partnership with Abbott Laboratories to bring together experts to develop guidelines for topics in rheumatology. It was Dr. Dougados who convinced Abbott to then invite steering committees from countries around the world, who used group dynamic voting to select questions and disease topics about which clinicians had uncertainty. The 3E platform was expanded to include young physicians who would be brought in as fellows to search the literature and find answers to the selected questions. Dr. Dougados drew upon his roster of international colleagues to become mentors for these young fellows, thus fostering a new generation of future leaders in the field. According to Dr. Bombardier, who has participated as a 3E mentor, Dr. Dougados insisted that the fellows who did research on the topics should be listed as first authors on the resulting papers.7 After five iterations of the 3E process, Dr. Dougados announced it was time for him to step down as a leader, a move that Dr. Bombardier says is emblematic of the way he acts as a change agent. “He’s open to international activity, he’s great at group dynamics, he thinks of the young people, but he also doesn’t want to control things forever—he steps down and lets other people try. And not a lot of senior rheumatologists are able to do that,” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many Talents

Dr. Dougados also has a knack for social settings, says Dr. Bombardier. He is a wonderful dancer, she notes, and he is generally regarded as a charming person. He enjoys golfing close to his summer home near Bordeaux, and Dr. Kvien recalls a happy fishing trip with a group of rheumatologists last June in Tromsø, Norway. “Maxime was a very enthusiastic fisherman and caught more codfish than anyone else,” he laughs. “He is a charming person with a good sense of humor and an enormous work capacity.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisPractice SupportProfiles

Related Articles

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    “A Common Language for Spondyloarthritis”

    December 1, 2010

    ASAS fills a niche, changes dogma with consensus approach

    The Key to Early Rheumatoid Arthritis

    September 1, 2010

    The conundrum of classification versus diagnosis

    Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

    September 11, 2020

    EULAR 2020 e-CONGRESS—In what speakers at the European e-Congress of Rheumatology described as the first treat-to-target and tight control (T2T/TC) strategy trial in axial spondyloarthritis (AxSpA), researchers found such a strategy has both health and financial benefits. In the year-long study—called TICOSPA—centers were randomized to apply either a T2T/TC strategy or care left to the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences